PE anti-human CD11b [ICRF44]
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0445530
- Awardee
- BIOLEGEND INC.
- Contracting organization
- University of Virginia
- Cumulative value
- $30.80
About this award
BIOLEGEND INC. was awarded a contract by the University of Virginia on June 4, 2026, for the procurement of immunological research materials. The primary deliverable under this contract is PE anti-human CD11b [ICRF44], a monoclonal antibody used in flow cytometry and immunological assays. The contract specifies delivery of one unit to Brandon K. Davidson, with a cumulative contract value of thirty dollars ($30.00).
This contract represents a minimal-value procurement from the University of Virginia, a state institution in Virginia. The single line item reflects the purchase of specialized laboratory reagents essential for biomedical research applications. The unit price of $30.80 for the PE-conjugated anti-human CD11b antibody is consistent with standard pricing for this type of research material. No additional details regarding the period of performance beyond the award date of June 4, 2026, are specified in the available documentation.
Line items
| Item | Total |
|---|---|
| PE anti-human CD11b [ICRF44] | $30.80 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0445530?
Contract A207_PO-0445530 was awarded to BIOLEGEND INC. by University of Virginia on June 4, 2026.
How much is contract A207_PO-0445530 worth?
Its cumulative value is $30.80.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award